Dreamm 3 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GSK's blood cancer drug Blenrep failed the main goal of a late-stage study designed to show it was better than an existing treatment on the market, the company said on Monday.

Blood cancer drugSierra oncologyBristol myers squibbJp morganDreamm 3South africaOwetan liveOod lifeReaking news